The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ropivacaine Injection Market Research Report 2024
Synopsis
Ropivacaine injection is used to cause numbness or loss of feeling in patients before and during surgery or labor and delivery. It is also used to relieve acute pain. Ropivacaine is a local anesthetic and does not cause loss of consciousness.
Global Ropivacaine Injection market is projected to reach US$ 1973.3 million in 2029, increasing from US$ 870 million in 2022, with the CAGR of 6.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ropivacaine Injection market research.
Anesthetics are an indispensable class of important chemical substances in modern clinical surgery. The mechanism of action is to inhibit and block the conduction of nerve impulses. It plays an important role in alleviating the pain of patients and promoting the development of surgical medicine. With the development of medicine, more attention is paid to the patient's somatosensory, and the increase of painless surgery has promoted this market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ropivacaine Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Akorn
Anant Pharmaceuticals
SGPharma
Nephron Pharmaceuticals
Sintetica SA
AstraZeneca
Manus Aktteva Biopharma LLP
Zhejiang Xianju Pharmaceutical Co.,Ltd
Jiangsu Nhwa Pharmaceutical Co.,Ltd.
Yangzi River Pharmaceutical Group
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Nhwa Pharmaceutical Co.,Ltd
Segment by Type
2 mg/mL (0.2%)
5 mg/mL (0.5%)
7.5 mg/mL (0.75%)
10 mg/mL (1%)
Segment by Application
Surgical Anesthesia
Major Nerve Block
Acute Pain Management
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ropivacaine Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Ropivacaine injection is used to cause numbness or loss of feeling in patients before and during surgery or labor and delivery. It is also used to relieve acute pain. Ropivacaine is a local anesthetic and does not cause loss of consciousness.
Global Ropivacaine Injection market is projected to reach US$ 1973.3 million in 2029, increasing from US$ 870 million in 2022, with the CAGR of 6.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ropivacaine Injection market research.
Anesthetics are an indispensable class of important chemical substances in modern clinical surgery. The mechanism of action is to inhibit and block the conduction of nerve impulses. It plays an important role in alleviating the pain of patients and promoting the development of surgical medicine. With the development of medicine, more attention is paid to the patient's somatosensory, and the increase of painless surgery has promoted this market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ropivacaine Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Akorn
Anant Pharmaceuticals
SGPharma
Nephron Pharmaceuticals
Sintetica SA
AstraZeneca
Manus Aktteva Biopharma LLP
Zhejiang Xianju Pharmaceutical Co.,Ltd
Jiangsu Nhwa Pharmaceutical Co.,Ltd.
Yangzi River Pharmaceutical Group
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Nhwa Pharmaceutical Co.,Ltd
Segment by Type
2 mg/mL (0.2%)
5 mg/mL (0.5%)
7.5 mg/mL (0.75%)
10 mg/mL (1%)
Segment by Application
Surgical Anesthesia
Major Nerve Block
Acute Pain Management
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ropivacaine Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Ropivacaine Injection Market Overview
1.1 Product Overview and Scope of Ropivacaine Injection
1.2 Ropivacaine Injection Segment by Type
1.2.1 Global Ropivacaine Injection Market Value Comparison by Type (2023-2029)
1.2.2 2 mg/mL (0.2%)
1.2.3 5 mg/mL (0.5%)
1.2.4 7.5 mg/mL (0.75%)
1.2.5 10 mg/mL (1%)
1.3 Ropivacaine Injection Segment by Application
1.3.1 Global Ropivacaine Injection Market Value by Application: (2023-2029)
1.3.2 Surgical Anesthesia
1.3.3 Major Nerve Block
1.3.4 Acute Pain Management
1.3.5 Other
1.4 Global Ropivacaine Injection Market Size Estimates and Forecasts
1.4.1 Global Ropivacaine Injection Revenue 2018-2029
1.4.2 Global Ropivacaine Injection Sales 2018-2029
1.4.3 Global Ropivacaine Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Ropivacaine Injection Market Competition by Manufacturers
2.1 Global Ropivacaine Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Ropivacaine Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Ropivacaine Injection Average Price by Manufacturers (2018-2023)
2.4 Global Ropivacaine Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Ropivacaine Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ropivacaine Injection, Product Type & Application
2.7 Ropivacaine Injection Market Competitive Situation and Trends
2.7.1 Ropivacaine Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ropivacaine Injection Players Market Share by Revenue
2.7.3 Global Ropivacaine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ropivacaine Injection Retrospective Market Scenario by Region
3.1 Global Ropivacaine Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Ropivacaine Injection Global Ropivacaine Injection Sales by Region: 2018-2029
3.2.1 Global Ropivacaine Injection Sales by Region: 2018-2023
3.2.2 Global Ropivacaine Injection Sales by Region: 2024-2029
3.3 Global Ropivacaine Injection Global Ropivacaine Injection Revenue by Region: 2018-2029
3.3.1 Global Ropivacaine Injection Revenue by Region: 2018-2023
3.3.2 Global Ropivacaine Injection Revenue by Region: 2024-2029
3.4 North America Ropivacaine Injection Market Facts & Figures by Country
3.4.1 North America Ropivacaine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Ropivacaine Injection Sales by Country (2018-2029)
3.4.3 North America Ropivacaine Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ropivacaine Injection Market Facts & Figures by Country
3.5.1 Europe Ropivacaine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Ropivacaine Injection Sales by Country (2018-2029)
3.5.3 Europe Ropivacaine Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ropivacaine Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Ropivacaine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Ropivacaine Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Ropivacaine Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ropivacaine Injection Market Facts & Figures by Country
3.7.1 Latin America Ropivacaine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Ropivacaine Injection Sales by Country (2018-2029)
3.7.3 Latin America Ropivacaine Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ropivacaine Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Ropivacaine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Ropivacaine Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Ropivacaine Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ropivacaine Injection Sales by Type (2018-2029)
4.1.1 Global Ropivacaine Injection Sales by Type (2018-2023)
4.1.2 Global Ropivacaine Injection Sales by Type (2024-2029)
4.1.3 Global Ropivacaine Injection Sales Market Share by Type (2018-2029)
4.2 Global Ropivacaine Injection Revenue by Type (2018-2029)
4.2.1 Global Ropivacaine Injection Revenue by Type (2018-2023)
4.2.2 Global Ropivacaine Injection Revenue by Type (2024-2029)
4.2.3 Global Ropivacaine Injection Revenue Market Share by Type (2018-2029)
4.3 Global Ropivacaine Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Ropivacaine Injection Sales by Application (2018-2029)
5.1.1 Global Ropivacaine Injection Sales by Application (2018-2023)
5.1.2 Global Ropivacaine Injection Sales by Application (2024-2029)
5.1.3 Global Ropivacaine Injection Sales Market Share by Application (2018-2029)
5.2 Global Ropivacaine Injection Revenue by Application (2018-2029)
5.2.1 Global Ropivacaine Injection Revenue by Application (2018-2023)
5.2.2 Global Ropivacaine Injection Revenue by Application (2024-2029)
5.2.3 Global Ropivacaine Injection Revenue Market Share by Application (2018-2029)
5.3 Global Ropivacaine Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Ropivacaine Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Akorn
6.2.1 Akorn Corporation Information
6.2.2 Akorn Description and Business Overview
6.2.3 Akorn Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Akorn Ropivacaine Injection Product Portfolio
6.2.5 Akorn Recent Developments/Updates
6.3 Anant Pharmaceuticals
6.3.1 Anant Pharmaceuticals Corporation Information
6.3.2 Anant Pharmaceuticals Description and Business Overview
6.3.3 Anant Pharmaceuticals Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Anant Pharmaceuticals Ropivacaine Injection Product Portfolio
6.3.5 Anant Pharmaceuticals Recent Developments/Updates
6.4 SGPharma
6.4.1 SGPharma Corporation Information
6.4.2 SGPharma Description and Business Overview
6.4.3 SGPharma Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SGPharma Ropivacaine Injection Product Portfolio
6.4.5 SGPharma Recent Developments/Updates
6.5 Nephron Pharmaceuticals
6.5.1 Nephron Pharmaceuticals Corporation Information
6.5.2 Nephron Pharmaceuticals Description and Business Overview
6.5.3 Nephron Pharmaceuticals Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Nephron Pharmaceuticals Ropivacaine Injection Product Portfolio
6.5.5 Nephron Pharmaceuticals Recent Developments/Updates
6.6 Sintetica SA
6.6.1 Sintetica SA Corporation Information
6.6.2 Sintetica SA Description and Business Overview
6.6.3 Sintetica SA Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sintetica SA Ropivacaine Injection Product Portfolio
6.6.5 Sintetica SA Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Ropivacaine Injection Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 Manus Aktteva Biopharma LLP
6.8.1 Manus Aktteva Biopharma LLP Corporation Information
6.8.2 Manus Aktteva Biopharma LLP Description and Business Overview
6.8.3 Manus Aktteva Biopharma LLP Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Manus Aktteva Biopharma LLP Ropivacaine Injection Product Portfolio
6.8.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
6.9 Zhejiang Xianju Pharmaceutical Co.,Ltd
6.9.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Corporation Information
6.9.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Description and Business Overview
6.9.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Product Portfolio
6.9.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
6.10 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
6.10.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Corporation Information
6.10.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Description and Business Overview
6.10.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Product Portfolio
6.10.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.11 Yangzi River Pharmaceutical Group
6.11.1 Yangzi River Pharmaceutical Group Corporation Information
6.11.2 Yangzi River Pharmaceutical Group Ropivacaine Injection Description and Business Overview
6.11.3 Yangzi River Pharmaceutical Group Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Yangzi River Pharmaceutical Group Ropivacaine Injection Product Portfolio
6.11.5 Yangzi River Pharmaceutical Group Recent Developments/Updates
6.12 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
6.12.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Corporation Information
6.12.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Description and Business Overview
6.12.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Product Portfolio
6.12.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.13 Jiangsu Nhwa Pharmaceutical Co.,Ltd
6.13.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Corporation Information
6.13.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Description and Business Overview
6.13.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Product Portfolio
6.13.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ropivacaine Injection Industry Chain Analysis
7.2 Ropivacaine Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ropivacaine Injection Production Mode & Process
7.4 Ropivacaine Injection Sales and Marketing
7.4.1 Ropivacaine Injection Sales Channels
7.4.2 Ropivacaine Injection Distributors
7.5 Ropivacaine Injection Customers
8 Ropivacaine Injection Market Dynamics
8.1 Ropivacaine Injection Industry Trends
8.2 Ropivacaine Injection Market Drivers
8.3 Ropivacaine Injection Market Challenges
8.4 Ropivacaine Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
